drugset / Trial / NCT02515851
Postsurgical Bupivacaine Extended-release Liposome Injection for Open-reduction Internal Distal Radius Fixation.
RandomizedParallel-groupTriple-blindTreatment
Summary
For patients undergoing open-reduction internal-fixaton (ORIF) of isolated distal radius fractures, administration of 66.5 mg of liposomal bupivacaine to operative field may decrease the need for post-operative narcotic pain medication.
Timeline
- Start
- 2015-08
- Primary completion
- 2016-08
- Completion
- 2016-08
Outcome
Outcome not reported
Stopped: “Unable to find sufficient drug naive patients”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 266 mg | Other |
Indications
No indication recorded.